Theme: Decoding Dementia and Alzheimer

Vascular Dementia 2019

Scientific Program

Renowned Speakers

Frank Galimidi
New Beginnings Recovery Center,
USA

Konstantin Slavin
University of Illinois ,
USA

Durodami Lisk
Ministry of Health,
USA

Peter Kaplan
Johns Hopkins University,
USA

Hemanth Rao
The Neurological Institute,
USA

Lucia M. Vaina
Boston University College of Engineering,
USA

Jennifer De Feo
Chicago School of Psychology,
USA

Chethan P. V. Rao
Baylor College of Medicine,
USA

Sepi Shokouhi
University Institute of Imaging Science,
USA

Jagdish Singh
Pharmaceutical Sciences School of Pharmacy,
USA

Christopher Winrow
Ironwood Pharmaceuticals,
USA

Markku Kurkinen
Wayne State University School of Medicine,
USA

Ramel Carlos
The Neurology Clinic,
USA

Amir Tamiz
National Institute of Health,
USA

Crissy Accordino
Specialty Care - IONM Division,
USA

James Gratwicke
National Hospital for Neurology and Neurosurgery,
UK

David Truswell
Culture Dementia,
UK

Jacqueline A Hinds
Society of Emotional Intelligence,
UK

Sally Gilmour
Old Age Psychiatry Pennine Care The Meadows Hospital,
UK

Diana Kljenak
Ontario Psychiatric Association,
Canada

Si Ching Lim
National University of Singapore,
Singapore

George Paxinos
University of New South Wales,
Australia

Alberto de bellis
Maria Rosaria Maglione Foundation o.n.l.u.s, Italy
Italy

Walter E. Muller
University of Frankfurt,
Germany

Semenov S. E
Institute for Complex Issues of Cardiovascular Diseases, Kemerovoa,
Russia

Hans Von Holst
Karolinska University Hospital
Sweden

Anne L. Foundas
Brain Institute of Louisiana,
USA

Brian Norris
Living Memories C.I.C.,
UK

Shu G. Chen
Case Western Reserve University School of Medicine,
USA

Nancy D. Broz
Rowan University,
USA

Kyaien O. Conner
University of South Florida
USA

Edward Chan
Malaysian Association of Psychotherapy
Malaysia

Amarnath Mallik
Consultant Psychiatrist,
India

Morejoy Saineti
Greenwich University,
UK

Vascular Dementia 2019

View the Tentative Program At here

Can We Cure Dementia, Vascular Dementia and Alzheimer's disease?

We invites all the participants from all over the world to attend 11^th International Conference on Vascular dementia during Feb 15-16, 2019 at Amsterdam, Netherlands with the Theme: Decoding Dementia & Alzheimer's disease, which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Our conference raises the following questions in Amsterdam, Netherlands:

What do you think are the biggest public misconceptions of Dementia, Vascular Dementia and Alzheimer's disease?
Will science ever discover a cure for Dementia, Vascular Dementia and Alzheimer's disease?
What recent scientific advances in treating or understanding Dementia, Vascular Dementia and Alzheimer's disease? would you say you are most amped up for?
How will these change the diagnosis of the disease?

Why to attend??

Vascular Dementia Conference is a unique forum to bring together worldwide distinguished academics in the field of Neuroscience and Neurology, Nutrition, Researchers, Public health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the Research and Development.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Vascular Dementia. A Unique Opportunity for Advertisers and Sponsors at this International event.

Target Group of onlookers:

Neurologists and Executives
Physicians
Neuroscientists
Specialists
Researchers
Health mind experts
Professors
Industrial Specialists
Neurosurgeons
Psychiatrist
Nutritional Researchers
Lecturers and Understudies from the scholarly world in the investigation of Dementia
Students from the scholarly community in the examination of Neurology

V ascular Dementia 2019 has been planned and implemented in accordance with the accreditation requirementsand policies of the Accreditation Committee

This educational activity will be accredited with CME and CPD Credits.

Attendance at this meeting will enable you to:

- Be part of a rich scientific programme incorporating the latest developments in preclinical neurodegenerative diseases like Dementia and Alzheimer's Diseases
- Understand the shift towards prevention and early diagnosis of neurodegenerative disease as the future of research in the field
- Join key opinion leaders in discussing regulatory and ethical implications of this research in clinical practice.
- Network with speakers and other leading experts across disciplines

Session on:

Session 1: Dementia

Dementia is not a specific disease. It's an overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Alzheimer's disease. Vascular dementia, which occurs after a stroke, is the second most common dementia type. But there are many other conditions that can cause symptoms of dementia, including some that are reversible, such as thyroid problems and vitamin deficiencies. Dementia is a syndrome that involves severe loss of cognitive abilities as a result of disease or injury. Dementia caused by traumatic brain injury is often static, whereas dementia caused by neurodegenerative disorders, such as Alzheimer's disease.

Related Associations:

Albanian Alzheimer Society, Asociación de Lucha contra el Mal de Alzheimer, Alzheimer's Disease Armenian Association, Fundacion Alzheimer Aruba , Dementia Australia, Alzheimer Austria, Alzheimer Support Group, Alzheimer Society of Bangladesh, Ligue Nationale Alzheimer Liga, Virgin Islands Alzheimer’s Awareness Advocate, Compassion Alzheimer Bulgaria, Alzheimer Society of Canada, Alzheimer Community Support of Burundi , Corporación Alzheimer Chile, Alzheimer's Disease Chinese, ÄŒeská alzheimerovská spoleÄnost Centre of Gerontology, Alzheimerforeningen, Association France Alzheimer, Deutsche Alzheimer Gesellschaft, Panhellenic Federation of Alzheimer's Disease and Related Disorders, Hungarian Alzheimer Society, Alzheimersamtökin, Alzheimer's & Related Disorders Society of India, Alzheimer's Indonesia Secretariat, Alzheimer's Association Japan, Association Luxembourg Alzheimer, Alzheimer's Disease Foundation Malaysia, Malta Dementia Society, Alzheimer Association Mauritius, Federación Mexicana de Alzheimer

Session 2: Vascular dementia

Vascular dementia is the broad term for dementia associated with problems of circulation of blood to the brain. There are a number of different types of Vascular dementia. Two of the most common are Multi-infarct dementia and Binswanger's disease. The multi-infarct dementia (MID) and vascular intellectual impedance is dementia caused by issues in the supply of blood to the mind, normally a progression of minor strokes. People with vascular dementiagive dynamic subjective hindrance, intensely or sub acutely as in mellow psychological debilitation, every now and again step-wise, after various cerebrovascular occasions (strokes). A few people may seem to enhance amongst occasions and decrease after more noiseless strokes. A quickly decaying condition may prompt demise from a stroke, coronary illness, or infection. Vascular dementia can be caused by ischemic or hemorrhagic infarcts influencing numerous mind regions, including the foremost cerebral supply route domain, the parietal projections, or the cingulate gurus.

Related Associations

Association Marocaine Alzheimer et Maladies Apparentées, Alzheimer Nederland, Alzheimers New Zealand, Nasjonalforeningen for folkehelsen, Oman Alzheimer’s Society, Asociacion Peruana de Enfermedad de Alzheimer y Otras Demencias, Alzheimer's Disease Association of the Philippines, Polish Alzheimer's Association, Associação Portuguesa de Familiares e Amigos de Doentes de Alzheimer, Asociación de Alzheimer y Desórdenes Relacionados de Puerto Rico, Qatar Alzheimer’s Society, Korean Association for Dementia (KAD), Romanian Alzheimer Society, Saudi Alzheimer's Disease Association, Alzheimer Scotland - Action on Dementia, Society for Population Dementia Alchajmer Group, Alzheimer's Disease Association, Sint Maarten Alzheimer Foundation, Slovak Alzheimer's Society , SpominÄica Alzheimer Slovenia, Alzheimer's South Africa, Confederación Española de Familiares de Enfermos de Alzheimer, Lanka Alzheimer's Foundation, Alzheimer Sverige, Association Alzheimer Suisse, Alzheimer’s Disease Tanzania, Alzheimer's and Related Disorders Association of Thailand, Association Alzheimer Tunisie, Turkish Alzheimer Association, The Association for the Problems of Alzheimer's Disease, Alzheimer's Society, Alzheimer's Association, Alzheimer Europe, Alzheimer Iberoamerica

Sessiom 3: Lewy body Dementia

Lewy body is also known as dementia with Lewy bodies, with Lewy body dementia is the second most common type of progressive dementia after Alzheimer's disease dementia. Protein deposits, called Lewy bodies, develop in nerve cells in the brain regions involved in thinking, memory and movement (motor control).

Lewy body dementia is also causes a progressive decline in mental abilities. The people with Lewy body dementia may experience visual hallucinations and changes in the alertness and attention and other effects include Parkinson's disease-like symptoms such as rigid muscles, slow movement and tremors.

Related Associations

Session 4: Amyloid Imaging in Dementia

Amyloid imaging is a technique performed in nuclear medicine. It uses PET ligands that allow in vivo detection of amyloid plaques, a core pathologic feature of Alzheimer disease and dementia.

Related Associations

Session 5: Alzheimers Disease

Alzheimer's disease (AD) is the most common form of dementia among older people. Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. AD begins slowly. It first involves the parts of the brain that control thought, memory and language. People with AD may have trouble remembering things that happened recently or names of people they know. A related problem, mild cognitive impairment (MCI), causes more memory problems than normal for people of the same age. Many, but not all, people with MCI will develop AD.

Related Associations

Session 6: Neurodegenerative Diseases

Neurodegenerative disease is an umbrella term for a range of conditions which primarily affect the neurons in the human brain. Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurons normally don’t reproduce or replace themselves, so when they become damaged or die they cannot be replaced by the body. Examples of neurodegenerative diseases include Parkinson’s, Alzheimer’s, and Huntington’s disease.

Related Associations

Session 7: Brain diseases

Brain Diseases come in different forms of Infections, trauma, stroke, seizures, and tumors are some of the major categories of brain diseases. Here's an overview of various diseases of the brain

Related Associations

Session 8: Ageing and Dementia

Almost 42% of people over the age of 64 experience some form of memory loss. When there is no underlying medical condition causing this memory loss, it is known as "age-associated memory impairment," which is considered a part of the normal aging process.

Related Associations

Session 9: Dementia Care Management

Dementia care management was provided at the homes of patients with dementia. Dementia care management is a model of collaborative care, defined as a complex intervention aiming to provide optimal treatment and care for patients with dementia and support caregivers using a computer-assisted assessment determining a personalized array of intervention modules and subsequent success monitoring. Dementia care management was targeted at the individual patient level and was conducted by nurses with dementia care-specific qualifications.

Related Associations

Session 10: Dementia Nursing

Caregivers of dementia patients need to understand dementia so that they can understand what the patient is going through. They need to know about underlying diseases, and how these may affect the progress of dementia. They also need to know what sort of behavior to expect. Understanding these helps them plan for their caregiving and to cope with the situation effectively, and with less stress.

Related Associations

Session 11: Treating Dementia

Treatment of dementia begins with the treatment of the underlying disease, where possible. The underlying causes of nutritional, hormonal, tumour-caused or drug-related dementia may be reversible to some extent. For many other diseases, such as Alzheimer's disease (AD), no cure has yet been discovered. However, improvement of cognitive and behavioural symptoms can be achieved through a combination of appropriate medications and other treatments, including psychotherapy.

Related Associations

Session 12: Neuropharmacology

Neuropharmacology is an extremely wide locale of science that includes numerous parts of the sensory system from single neuron control to whole ranges of the cerebrum, spinal line, and fringe nerves. To better comprehend the premise behind medication advancement, one should first see how neurons speak with each other. This article will concentrate on both behavioral and atomic neuropharmacology; the real receptors, particle channels, and neurotransmitters controlled through medication activity and how individuals with a neurological issue advantage from this medication activity.

Related Associations

Session 13: Novel therapeutics

The purpose of the session is to consider the use of novel therapeutics for the treatment of dementia and Neurological disorders, Multiple Sclerosis etc. Novel therapeutics includes use of nanotechnology to treat Neurological disorders and CNS disorders and molecular therapeutics based diagnosis etc.

Related Associations

Session 14: Animal Models in Dementia

The animal models of dementia and Alzheimer's disease. for pre-clinical testing and clinical translation. Dementia is a clinical syndrome with abnormal degree of memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease.

Related Associations

Session 15: Neuro Oncology and CNS

It is a branch of Medical Sciences majorly deals with Neuro tumors. Deals with Studies related to Brain and Spinal cord neoplasms. Neuro-oncology and Pediatric Neuro-oncology are the two different Concepts that differentiate the determining methodology of Neuro tumors. Neuro-oncology mainly includes especially related topics like Radiation therapy, Neurosurgery, Neuroimaging, social, Psychological, Neuropathology and psychiatric aspects.

Related Associations

For conference attendance and participation only Business Visa should be applied. Contact your nearest travel agent/visa information center/ Netherlnads Embassy for the correct application form.

All visas for visiting / Netherlnads shall be processed by respective authorities only upon submission of proper documents through proper channel.

In case of non-furnishing of documents, non-adherence to guidelines visas shall be cancelled by respective authorities.

The minimum supportive documents that might be required while applying for / Netherlnads visa include:

Letter of invitation,

Abstract acceptance letter (if speaker),

Registration payment receipt,

Accommodation confirmation letter issued under conference letter head.

For letter of invitation and accommodation confirmation, payment of registration fees and accommodation charges is a pre-requisite.

Mandate documents required from conference secretariat should be obtained only through Rose Watson

For more details please contact

Rose Watson

Program Manager

Vascular Dementia 2019

E: ICVD2019@europemeet.com

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	February 15-16, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View